Crohn's Disease

Johnson & Johnson shows off under-pressure Stelara's latest indication—Crohn's—in new DTC spot
Johnson & Johnson shows off under-pressure Stelara's latest indication—Crohn's—in new DTC spot
Fierce Pharma
JNJ
Stelara
Crohn's Disease
drug advertising
DTC ads
Flag link:
Johnson & Johnson commits $990M to land Protagonist’s oral Crohn’s drug
Johnson & Johnson commits $990M to land Protagonist’s oral Crohn’s drug
Fierce Biotech
JNJ
Protagonist Therapeutics
M&A
Crohn's Disease
PTG-200
Flag link:
AbbVie's JAK-1 inhibitor hits the mark in Crohn's disease
AbbVie's JAK-1 inhibitor hits the mark in Crohn's disease
BioPharma Dive
AbbVie
JAK inhibitors
Crohn's Disease
Upadacitinib
Flag link:
Pfizer and Celltrion Seek Biosimilar Interchangeability for Crohn’s Disease Drug
Pfizer and Celltrion Seek Biosimilar Interchangeability for Crohn’s Disease Drug
Xtalks
Pfizer
Celltrion
biosimilars
Crohn's Disease
Inflectra
Remicade
Flag link:
Takeda, TiGenix stem cell therapy shows sustained effect
Takeda, TiGenix stem cell therapy shows sustained effect
Fierce Biotech
Takeda
TiGenix
stem cells
Cx601
Crohn's Disease
Flag link:
Gilead Takes Lead on Crohn's over AbbVie
Gilead Takes Lead on Crohn's over AbbVie
Investopedia
Gilead Sciences
AbbVie
Crohn's Disease
Galapagos
filgotinib
ABT-494
Flag link:
Celgene Skips the Placebo, Fails Drug Development 101
Celgene Skips the Placebo, Fails Drug Development 101
TheStreet.com
Celgene
drug development
clinical trials
placebo
GED-0301
Crohn's Disease
Flag link:
Celgene Crohn's Pill Data Unspectacular but Perhaps Good Enough
Celgene Crohn's Pill Data Unspectacular but Perhaps Good Enough
TheStreet.com
Celgene
Crohn's Disease
GED-0301
Flag link:
Could J&J's recent news about its rheumatoid arthritis and Crohn's disease drugs threaten AbbVie's Humira?
Could J&J's recent news about its rheumatoid arthritis and Crohn's disease drugs threaten AbbVie's Humira?
Motley Fool
JNJ
rheumatoid arthritis
Crohn's Disease
AbbVie
Humira
sirukumab
Flag link:
AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
Endpoints
AstraZeneca
Amgen
Allergan
MEDI2070
ulcerative colitis
Crohn's Disease
Flag link:
Will Gilead (GILD) Stock Be Helped by Positive Crohn's Drug Results?
Will Gilead (GILD) Stock Be Helped by Positive Crohn's Drug Results?
TheStreet.com
Gilead Sciences
Crohn's Disease
filgotinib
Galapagos
Flag link:
Celgene’s update on its big Crohn’s drug? Trust us, we’re doing fine
Celgene’s update on its big Crohn’s drug? Trust us, we’re doing fine
Endpoints
Celgene
Crohn's Disease
GED-0301
Flag link:
How AbbVie Expects Risankizumab to Be a Transformative Therapy
How AbbVie Expects Risankizumab to Be a Transformative Therapy
Market Realist
AbbVie
risankizumab
Crohn's Disease
Flag link:
Next Up for Celgene's Crohn's Pill: A Snapshot Inside Patients' Colons
Next Up for Celgene's Crohn's Pill: A Snapshot Inside Patients' Colons
TheStreet.com
Celgene
Crohn's Disease
GED-0301
Otezla
ozanimod
Flag link:
AbbVie’s Newly Licensed Drug Scores Against Crohn’s Disease
AbbVie’s Newly Licensed Drug Scores Against Crohn’s Disease
Investors.com
AbbVie
Crohn's Disease
risankizumab
Boehringer Ingelheim
Flag link:
J&J psoriasis drug Stelara tames Crohn's disease in second trial
J&J psoriasis drug Stelara tames Crohn's disease in second trial
Yahoo/Reuters
JNJ
psoriasis
Stelara
Crohn's Disease
Flag link:
Galapagos' inflammation drug comes through in Crohn's with Phase III in sight
Galapagos' inflammation drug comes through in Crohn's with Phase III in sight
Fierce Biotech
Galapagos
Crohn's Disease
filgotinib
Flag link:
AstraZeneca Sells Drug Rights To Perrigo
AstraZeneca Sells Drug Rights To Perrigo
Bidness, ETC
AstraZeneca
Perrigo Company
Entocort
Crohn's Disease
Flag link:
J&J's Stelara succeeds in Phase III Crohn's disease trial
J&J's Stelara succeeds in Phase III Crohn's disease trial
Yahoo/Reuters
JNJ
Stelara
Crohn's Disease
clinical trials
Flag link:
Does Celgene Have Another Blockbuster on the Way?
Does Celgene Have Another Blockbuster on the Way?
Investopedia
Celgene
GED-0301
autoimmune disease
Crohn's Disease
Flag link: